This is where the research gets especially compelling
(l always preferred red wine to white, but since going on a GLP-1 medication, Ive done a complete 180
Cardiovascular Risk Indication In 2024, semaglutide 2.4 mg (Wegovy) received an additional FDA indication: reduction of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight
This information can be very useful in helping you to make the necessary changes to your diet and exercise routine
But there have also been reports of individuals taking GLP-1 medications, like semaglutide, who developed kidney issues, including worsening chronic kidney failure, especially if experiencing significant nausea or vomiting
Below is a list of some vitamins and supplements that have been recently studied regarding their use with individuals with ASD